Notícias

Since the first cases of COVID-19 were documented in Wuhan, China in 2019, the world has witnessed a devastating global...

COVID-19 is characterized by vascular inflammation and thrombosis, including elevations in P-selectin, a mediator of inflammation released by endothelial cells....

After promising initial results from the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) to...

The emergence of the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 and the reduced effectiveness over time...

O advogado Pedro Marcos Barbosa foi o homenageado na 6ª edição do Prêmio Denis Barbosa, em cerimônia realizada no dia...

Immunological memory is a hallmark of adaptive immunity and facilitates an accelerated and enhanced immune response upon re-infection with the...

A new coronavirus disease named COVID-19, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is rapidly spreading worldwide. However, there...

Anti-severe acute respiratory syndrome coronavirus 2 mRNA vaccines elicit lower humoral responses in solid-organ transplant recipients. This is the first...

Divulgação MJSP

A 6ª reunião ordinária do Conselho Nacional de Combate à Pirataria (CNCP), foi realizada em clima de comemoração...

Given the importance of flexible use of different COVID-19 vaccines within the same schedule to facilitate rapid deployment, we studied...

O Comitê-Executivo de Gestão da Câmara de Comércio Exterior (Gecex/Camex) aprovou na última segunda-feira (29/11) a Resolução Gecex nº 272,...

SARS-CoV-2 is highly homologous to SARS-CoV. To date, the main protease (Mpro) of SARS-CoV-2 is regarded as an important drug...